Unclear Diagnoses in Patients with Metastatic Disease

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia addresses the problem of unclear diagnoses affecting approximately 15% of newly diagnosed patients with metastatic disease each year and the importance of an accurate diagnosis of tumor type in selecting the proper site-specific therapies.
September 20, 2013

Justifying the Value of Personalized Medicine

Matthew Palmgren presents the key issues that help justify the value and cost of personalized medicines

January 13, 2015

BCI Affects and Survivorship

Dr Susan K. Boolbol talks about the importance of objective evidence provided by the Breast Cancer IndexSM (BCI) in treatment decision making.